Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberdeen Uk Sm. Regulatory News (AUSC)

Share Price Information for Aberdeen Uk Sm. (AUSC)

Share Price is delayed by 15 minutes
Get Live Data
496.00    2.00 (0.40%)
Bid:
493.50
Ask:
497.50
Spread: 4.00 (0.811%)
Market Cap: £228.72m
AUSC Live PriceLast checked at - London Stock Exchange

Intraday Aberdeen Uk Sm. Share Chart

Amendment to Management Fee

3 Apr 2025 07:00

RNS Number : 4110D
abrdn UK Smaller Cos. Growth Trust
03 April 2025
 

3 April 2025

 

abrdn UK Smaller Companies Growth Trust plc

Legal Entity Identifier (LEI): 213800UUKA68SHSJBE37

 

 

Amendment to Management Fee

 

The Board of abrdn UK Smaller Companies Growth Trust plc (the "Company") is pleased to announce that it has agreed a change to the terms of the management fee payable by the Company to Aberdeen Investments ("Aberdeen").

 

With effect from 1 April 2025, the Company's management fee will continue to be charged on a tiered basis, but at reduced rates of 0.60% per annum on the first £200 million of the Net Asset Value ("NAV") and 0.55% on NAV above this figure.

 

Prior to 1 April 2025, the Company's management fee was charged at a rate of 0.75% per annum of the NAV up to £175 million, 0.65% above £175 million and below £550 million, and 0.55% above £550 million.

 

Save for this change, all other terms and conditions contained in the Company's Management Agreement remain unchanged.

 

Liz Airey, Chairman of the Company commented "The Board is pleased to announce this change in the management fee with Aberdeen. We believe that this arrangement will reduce the cost of managing the portfolio by approximately 17.5% per annum to the benefit of all shareholders. As this change is being implemented with only three months of the current financial year left to run, the impact will be more limited in the year to 30 June 2025. However, had the new management fee arrangement been in place for the whole of the financial year to 30 June 2024, then the ongoing charges ratio ("OCR") would have been around 0.80%, rather than the reported 0.92%. The Board considers that this revised fee structure makes the Company more competitive.

 

 

For further information, please contact:

 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZGGDKZKGKZM
Date   Source Headline
24th Sep 20255:09 pmRNSTransaction in Own Shares
24th Sep 202512:36 pmRNSNet Asset Value(s)
23rd Sep 20255:21 pmRNSTransaction in Own Shares
23rd Sep 20253:07 pmRNSDoc re. Annual Report
23rd Sep 202511:34 amRNSNet Asset Value(s)
22nd Sep 20255:27 pmRNSTransaction in Own Shares
22nd Sep 20253:09 pmRNSGearing disclosure
22nd Sep 202512:17 pmRNSNet Asset Value(s)
19th Sep 20255:13 pmRNSTransaction in Own Shares
19th Sep 202510:48 amRNSNet Asset Value(s)
18th Sep 20255:16 pmRNSTransaction in Own Shares
18th Sep 202511:20 amRNSNet Asset Value(s)
17th Sep 20255:19 pmRNSTransaction in Own Shares
17th Sep 202511:47 amRNSNet Asset Value(s)
16th Sep 20255:28 pmRNSTransaction in Own Shares
16th Sep 202510:56 amRNSNet Asset Value(s)
15th Sep 20255:32 pmRNSTransaction in Own Shares
15th Sep 20252:34 pmRNSGearing disclosure
15th Sep 202511:30 amRNSNet Asset Value(s)
12th Sep 20255:10 pmRNSTransaction in Own Shares
12th Sep 202512:05 pmRNSNet Asset Value(s)
12th Sep 20259:15 amRNSPortfolio disclosure
11th Sep 20255:08 pmRNSTransaction in Own Shares
11th Sep 202511:44 amRNSNet Asset Value(s)
10th Sep 20255:13 pmRNSTransaction in Own Shares
10th Sep 202511:40 amRNSNet Asset Value(s)
9th Sep 20255:09 pmRNSTransaction in Own Shares
9th Sep 202510:53 amRNSNet Asset Value(s)
8th Sep 20255:06 pmRNSTransaction in Own Shares
8th Sep 20251:49 pmRNSGearing disclosure
8th Sep 202512:04 pmRNSNet Asset Value(s)
5th Sep 202512:22 pmRNSNet Asset Value(s)
4th Sep 20252:59 pmRNSMonth End Net Asset Value(s)
4th Sep 202511:05 amRNSNet Asset Value(s)
4th Sep 20257:00 amRNSAnnual Financial Report
3rd Sep 202512:35 pmRNSNet Asset Value(s)
2nd Sep 202511:34 amRNSNet Asset Value(s)
1st Sep 202511:19 amRNSGearing disclosure
1st Sep 202510:19 amRNSTotal Voting Rights
29th Aug 202512:29 pmRNSNet Asset Value(s)
28th Aug 202511:31 amRNSNet Asset Value(s)
27th Aug 202512:58 pmRNSNet Asset Value(s)
26th Aug 20255:10 pmRNSTransaction in Own Shares
26th Aug 202512:00 pmRNSGearing disclosure
26th Aug 202511:16 amRNSNet Asset Value(s)
22nd Aug 20255:18 pmRNSTransaction in Own Shares
22nd Aug 202512:31 pmRNSNet Asset Value(s)
21st Aug 20255:16 pmRNSTransaction in Own Shares
21st Aug 202511:58 amRNSNet Asset Value(s)
20th Aug 202512:25 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.